PharVision Advisers’s Ares Commercial Real Estate ACRE Stock Holding History
Bought
Maintained
Sold
Other funds holding ACRE
CC
LIP
CWA
AGM
PharVision Advisers's ACRE Position: Q1 2026 in Review
PharVision Advisers sold out of Ares Commercial Real Estate (ACRE) in Q1 2026, closing a stake of 26,066 shares — an estimated $125K sold.
PharVision Advisers first reported a position in ACRE in Q4 2025 and held it in 1 quarter. The position peaked at $125K in Q4 2025. 138 funds tracked by Wall St. Rank hold ACRE as of Q1 2026.
- PharVision Advisers reported no remaining Ares Commercial Real Estate position as of Q1 2026 after selling out during the quarter.
- PharVision Advisers sold 26,066 Ares Commercial Real Estate shares in Q1 2026, an estimated $125K.
- PharVision Advisers first reported a position in Ares Commercial Real Estate in Q4 2025 and held it in 1 quarter.
- PharVision Advisers's Ares Commercial Real Estate position peaked at $125K in Q4 2025.
- 138 funds tracked by Wall St. Rank held Ares Commercial Real Estate as of Q1 2026.
Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.